Growing public awareness related to the therapeutic potency of stem cells to drive the growth of global stem cell therapy market
According to TechSci Research Report, “Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025”, the global stem cell therapy market is expected to grow at a formidable rate of around 12% through 2025 on account of increased awareness about umbilical stem cell, growing demand for regenerative treatment options, among others. Additionally, rising R&D initiatives to develop therapeutic options for chronic diseases and increase in the approval for clinical trials in stem cell research are further expected to spur the market during forecast years. However, high cost of the procedure can hamper the growth of market during forecast period. Moreover, regulatory complications and ethical & moral framework can further restrict the growth of market.
The global stem cell therapy market is segmented based on type, source of stem cells, application, end users, company and region. Based on source of stem cells, the market can be fragmented into adipose tissue, bone marrow, neural, embryo/cord blood derived, iPSCs and others. The embryo/cord blood derived segment is expected to dominate the market during forecast years. This can be ascribed to the higher totipotency and indefinite lifespan of embryonic stem cells. Based on application, the market can be categorized into musculoskeletal, wound & injury, cardiovascular disease (CVD), surgery, acute graft-versus-host disease, drug discovery & development and others. The musculoskeletal segment is expected to dominate the market during the next five years owing to the factors such as larger number of commercialized stem cell therapy products for the treatment of musculoskeletal disorders and the increasing prevalence of musculoskeletal disorders.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “ Global Stem Cell Therapy Market“
Industry Players :
Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others are some of the leading players operating in global stem cell therapy market.
“Asia-Pacific is expected to witness significant growth in stem cell therapy market during the forecast period owing to the increasing awareness amongst people pertaining to benefits of advanced stem cell therapies in the region. Additionally, favourable initiatives undertaken by several organizations are expected to promote industry players to come up with innovative solutions. For instance, according to Pharma Focus Asia, members of Asia-Pacific Economic Cooperation collaborated with Life Sciences Innovation Forum to involve professionals having expertise in stem cell therapies from academia and research centers to promote developments in stem cell research. Moreover, vast research studies taking place in countries such as Singapore and Japan are further expected to propel the market through 2025.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4488
Customers can also request for 10% free customization on this report.
“Global Stem Cell Therapy Market By Type, By Source of Stem Cells, By Application, By End Users, By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global stem cell therapy market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global stem cell therapy market.
Global stem cell therapy market is expected to grow at a formidable rate of around 12% during the forecast period. The global stem cell therapy market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.
The global stem cell therapy market is segmented based on type, source of stem cells, application, end users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.
Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.
About Us :
TechSci Research is a research based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
Email : [email protected]
Website : https://www.techsciresearch.com/